Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
RationaleNicotine-induced cognitive enhancement may be a factor maintaining tobacco smoking, particularly in psychiatric populations suffering from cognitive deficits. Schizophrenia patients exhibit higher smoking rates compared with the general population, suggesting that attempts to self-medicate cognitive schizophrenia deficits may underlie these high smoking levels.ObjectivesThe present study explored pro-cognitive effects of nicotine in a model of schizophrenia-like cognitive dysfunction to test this self-medication hypothesis.Materials and methodsWe investigated whether chronic nicotine (3.16 mg/kg/day, base) would attenuate the performance disruption in the five-choice serial reaction time task (5-CSRTT, a task assessing various cognitive modalities, including attention) induced by repeated administration of phencyclidine (PCP), an N-methyl-d-aspartate receptor antagonist that induces cognitive deficits relevant to schizophrenia.ResultsChronic nicotine administration shortened 5-CSRTT response latencies under baseline conditions. Nicotine-treated rats also made more correct responses and fewer omissions than vehicle-treated rats. Replicating previous studies, repeated PCP administration (2 mg/kg, 30 min before behavioral testing for two consecutive days followed 2 weeks later by five consecutive days of PCP administration) decreased accuracy and increased response latencies, premature responding, and timeout responding. Chronic nicotine did not attenuate these PCP-induced disruptions.ConclusionsChronic nicotine had pro-cognitive effects by itself, supporting the hypothesis that cognitive enhancement may contribute to tobacco smoking. At the doses of nicotine and PCP used, however, no support was found for the hypothesis that the beneficial effects of nicotine on cognitive deficits induced by repeated PCP administration, assessed in the 5-CSRTT, are larger than nicotine effects in the absence of PCP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evenden, J. L. (1999) · Psychopharmacology · doi:10.1007/pl00005481 · Cited by 2,044 · cited 2×
“In addition, the 5-CSRTT includes measures of disinhibition of inappropriate responding and has become recognized as a test of impulsivity (Puumala et al. 1996; Evenden 1990).”
BackgroundPrevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · cited 2×
“patients is nearly 90% (Hughes et al. 1986), with most patients being heavy smokers (De Leon et al.”
BackgroundCognitive Impairment in Schizophrenia Is the Core of the Disorder
Elvevag, B., & Goldberg, T. E. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.10 · Cited by 835 · cited 2×
“Schizophrenia is a severe psychiatric disorder characterized by profound cognitive deficits (Elvevag and Goldberg 2000) that affect a wide range of cognitive modalities, including attention (Laurent et al. 1999), processing speed (Nelson et al. 1990), response inhibition/impulse control (Wykes et…”
BackgroundNicotinic receptor subtypes and cognitive function
Levin, E. D. (2002) · Journal of Neurobiology · doi:10.1002/neu.10151 · Cited by 354
Rodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · cited 2×
“The dose chosen here (3.16 mg/kg/day nicotine base) generates stable plasma nicotine levels (44 ng/ml) comparable to those achieved by heavy smokers consuming ∼30 cigarettes per day (Benowitz 1988) and produces dependence in rats within as little as 7 days (Malin et al. 1992).”
BackgroundInfluentialGioanni, Y., Rougeot, C., Clarke, P. B. S., Lepousé, C., Thierry, A. M., & Vidal, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00403.x · Cited by 191 · cited 2×
“Nicotine-induced increases in glutamate release (Gioanni et al. 1999) may mediate cognitive-enhancing effects of nicotine.”
BackgroundRodefer, J. S., Nguyen, T. N., Karlsson, J.-J., & Arnt, J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301654 · Cited by 126
(1993) · doi:10.1016/0376-8716(93)90041-n · Cited by 77
Warburton, D. M., Rusted, J. M., & Fowler, J. (1992) · Psychopharmacology · doi:10.1007/bf02247418 · Cited by 72 · cited 2×
“Studies in humans found enhanced attentional performance after cigarette smoking or other nicotine administration (Wesnes and Warburton 1983, 1984a, b; Rusted and Warburton 1992; Warburton et al. 1992; Parrott and Craig 1992; Bates et al. 1995).”
BackgroundRusted, J. M., & Warburton, D. M. (1992) · Psychopharmacology · doi:10.1007/bf02247420 · Cited by 68 · cited 6×
“Nicotine, one of the major psychoactive components of tobacco smoke, can improve aspects of cognition (Mangan 1983; Peeke and Peeke 1984), particularly attention ( Rusted and Warburton 1992; Warburton et al. 1992; Parrott and Craig 1992; Bates et al. 1995).”
BackgroundInfluential
Cited by
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.019 · Cited by 123
Jeevakumar, V., Driskill, C., Paine, A., Sobhanian, M., Vakil, H., Morris, B., Ramos, J., & Kroener, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.010 · Cited by 84
Metadata
- Authors
- Amitai, N., & Markou, A.
- Venue
- Psychopharmacology
- Published
- 2008-07-11
- Volume
- 202
- Issue
- 1-3
- Pages
- 275-286
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2000524211
- Cited by
- 50
- References
- 10
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration. https://app.cochat.ai/papers/10.1007/s00213-008-1246-0
- The paper
- Amitai, N., & Markou, A. (2009). Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration. Psychopharmacology. https://doi.org/10.1007/s00213-008-1246-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.